Hologic to Acquire Spanish Precision Oncology Startup Reveal Genomics
Hologic announced a definitive agreement to acquire Spanish startup Reveal Genomics, marking a major milestone for the company and expanding Hologic’s portfolio in precision oncology. The deal will integrate Reveal’s breast‑cancer genomic testing platform into Hologic’s women’s‑health technology suite.